20-F/A

AMENDMENT NO. 1 TO ANNUAL REPORT

Company: Can-Fite BioPharma Ltd.
Filed: April 2, 2019
Period of Report: December 31, 2018
Accession Number: 0001213900-19-005569

View Document ↗ View on SEC.gov ↗